Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Archos ( (FR:ALJXR) ) is now available.
ARCHOS reported a significant financial turnaround in 2024, with a 59% increase in revenue to 31.4 million euros and a net profit of 1.4 million euros, marking a return to profitability. The company achieved growth across its divisions, notably with a 100% increase in its Health division and a 66% growth in its Defense and Industry division. Looking ahead, ARCHOS aims to double its revenue in 2025, supported by strategic acquisitions and contracts, including a major defense contract in Germany and the launch of new products.
More about Archos
ARCHOS is a French company known for its expertise in mobile solutions, particularly in the consumer electronics sector and B2B markets through its subsidiary LOGIC INSTRUMENT. The company was a pioneer in offering Google Android tablets and has expanded into the MedTech sector with its Medical Devices Venture. ARCHOS operates with a pan-European presence and is listed on the Euronext Growth Paris market.
YTD Price Performance: 77.27%
Average Trading Volume: 18,832
Technical Sentiment Signal: Buy
Current Market Cap: €11.55M
Find detailed analytics on ALJXR stock on TipRanks’ Stock Analysis page.